FEBA GEEVARGHESE: Open Payments
NPI 1134671605 · WILLOW GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 64 payments from 14 companies in 2025. Trend: 2023 $1,478 · 2024 $2,240 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 7 | $304 |
| Abbott Laboratories | 6 | $208 |
| Collegium Pharmaceutical, Inc. | 14 | $192 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $163 |
| SCILEX PHARMACEUTICALS INC. | 9 | $158 |
| Alkermes, Inc. | 4 | $140 |
| Boston Scientific Corporation | 3 | $129 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $75 |
| Zimmer Biomet Holdings, Inc. | 1 | $49 |
| Valinor Pharma, LLC | 2 | $47 |
Products named: QUTENZA, XTAMPZA, PROCLAIM, RELISTOR, ZTLido, VIVITROL, WaveWriter Alpha Prime 16, JOURNAVX.
Industry payments across PA — which companies pay providers there.
